Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy
Patients with low FAR had significantly better prognostic outcomes than those with high FAR when receiving immunochemotherapy. Thus, FAR may serve as a valuable prognostic biomarker for predicting survival outcomes in patients with advanced HER2-negative GC.
Authors
- Yan Fang (ORCID: https://orcid.org/0000-0001-5291-7345)
- Zhiyuan Yao (ORCID: https://orcid.org/0000-0002-5759-9822)
- Zhengxiang Han (ORCID: https://orcid.org/0000-0003-2463-8933)
- Chunhua Yang (ORCID: https://orcid.org/0009-0001-9070-0638)
- Yu Cui (ORCID: https://orcid.org/0000-0002-3480-0730)
- Jie Liu (ORCID: https://orcid.org/0000-0002-4966-1753)
- Xiao Ma (ORCID: https://orcid.org/0000-0001-7792-9457)
- Wanting Li (ORCID: https://orcid.org/0000-0002-9519-8624)
- Yu Shen (ORCID: https://orcid.org/0000-0001-5717-7745)
Institutions
- Xuzhou Medical College (CN)
- Suzhou Municipal Hospital (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-06-13
- DOI
- https://doi.org/10.4251/wjgo.v17.i6.107980
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00